ArticleOPEN ACCESS

Is it time to shift the monotherapy after percutaneous coronary intervention from aspirin to P2Y12 inhibitors? ― New normal in the new-generation era ―

Circulation Journal
DOI: 10.1253/circj.CJ-21-0026
0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Natsuaki, M., & Node, K. (2021). Is it time to shift the monotherapy after percutaneous coronary intervention from aspirin to P2Y12 inhibitors? ― New normal in the new-generation era ―. Circulation Journal. Japanese Circulation Society. https://doi.org/10.1253/circj.CJ-21-0026

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free